HUMA: Humacyte Inc

HUMA新闻

• 23:00 Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know
• 19:40 BTIG重申Humacyte股票买入评级，关注国防部资金消息
• 19:39 BTIG reiterates Buy rating on Humacyte stock amid DoD funding news
• 14:46 Humacyte股价在获得国防部血管修复技术资金后跳升
• 14:42 Humacyte stock jumps after securing DoD funding for vascular repair tech
• 13:22 国防部在2026年预算中为生物工程血管修复技术拨款
• 13:19 DoD allocates funds for bioengineered vascular repair tech in 2026 budget
• 23:00 Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider
• 14:59 基准下调Humacyte股票目标价至10美元，因以色列申请计划
• 14:57 Benchmark lowers Humacyte stock price target to $10 on Israel filing plans
• 14:40 Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year?
• 13:22 Humacyte plans to seek approval for vessel product in Israel
• 13:05 Humacyte secures up to $77.5 million credit facility with Avenue Capital
• 14:30 Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest?
• 12:26 H.C. Wainwright重申Humacyte股票买入评级
• 12:24 Humacyte stock rating reiterated at Buy by H.C. Wainwright
• 14:30 Should You Invest in Humacyte, Inc. (HUMA) Based on Bullish Wall Street Views?
• 15:13 Benchmark下调Humacyte股票目标价至11美元，因收入延迟
• 15:12 Benchmark lowers Humacyte stock price target to $11 on delayed revenue
• 13:30 Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates
• 12:30 Humacyte Q3 每股收益 超出预期, 营收 低于预期
• 12:30 Humacyte earnings beat by $0.05, revenue fell short of estimates
• 13:05 Humacyte’s bioengineered vessel shows superior results in dialysis patients
• 23:00 Humacyte, Inc. (HUMA) Declines More Than Market: Some Information for Investors